FOLH1 and prostate cancer: PSMA contains a carboxypeptidase that is thought to cleave glutamate from vitamin B9, possibly activating the phosphoinositide 3-kinase pathway and promoting prostate cancer growth independent of the androgen receptor (AR) pathway [5].